Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

European Stocks Edge Higher; Economic Data Cheer

Published 12/18/2020, 04:02 AM
Updated 12/18/2020, 04:02 AM
© Reuters.

By Peter Nurse 

Investing.com - European stock markets edged cautiously higher Friday, with investors optimistic about future growth despite keeping a wary eye on the ongoing Brexit negotiations.

At 4:05 AM ET (0905 GMT), the DAX in Germany traded 0.3% higher, the CAC 40 in France rose 0.3%, while the U.K.'s FTSE index outperformed, climbing 0.6%. 

European Commission President Ursula von der Leyen said late Thursday that  “big differences” remain between the two sides, and that “bridging them will be very challenging.”

A spokesman for U.K. Prime Minister Boris Johnson also warned it was “very likely” there would be no agreement unless the bloc changed its position “substantially”.

Talks are progressing behind the scenes, and such negative language could be expected as a negotiating tactic, but time is running out for the two sides to agree a deal to cover around $1 trillion in annual trade at risk of facing tariffs and quotas at the end of the year.

This potential disruption to the European economy as a whole comes as the region continues to suffer from the effects of the Covid-19 pandemic. 

That said, Friday’s economic data have been reasonably positive. The widely-watched German IFO Business Climate index climbed to 92.1 in December from 90.7 the previous month. U.K. consumer confidence also rose in December, helped by the start of the country’s vaccination program, while retail sales dropped by 3.8% in November. This was the biggest decline since the first lockdown in April, but was still better than the 4.2% drop expected.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Additionally, an advisory panel in the U.S. recommended the approval of Moderna 's  (NASDAQ:MRNA) Covid-19 drug late Thursday, clearing the way for a second vaccine to enter the fight against the pandemic.

In corporate news, British Airways-owner IAG (LON:ICAG) stock fell 0.9% after a report that it had agreed to buy Spanish carrier Air Europa for 500 million euros ($612.55 million).

Vivendi (PA:VIV) stock rose 1.6% after the French conglomerate agreed to sell another stake of 10% in Universal Music Group to Tencent Holdings (OTC:TCEHY), the latest in a string of eye-catching deals in music that has underlined the value of rights holders' income streams.

Dutch health technology firm Philips (AS:PHG) rose 2.3% after it agreed to buy U.S. cardiac diagnostics and monitoring firm BioTelemetry (NASDAQ:BEAT) in a deal worth $2.8 billion.

Oil prices slipped, retreating from the nine-month highs seen the previous session as traders waited for Congress to approve a new Covid-19 relief package.

U.S. crude futures traded 0.1% lower at $48.34 a barrel, while the international benchmark Brent contract fell 0.2% to $51.39. Both benchmarks hit their highest levels since early March on Thursday.

Elsewhere, gold futures fell 0.3% to $1,885.50/oz, while EUR/USD traded 0.1% lower at 1.2260.

 

Latest comments

It’s China data helps
why china data doesn't help china?
brainwashed consumers feel confidence midst pandemic
EU stocks up and brexit talk advance: “Up amid brexit hope”EU stock up and brexit talk stopped: “Up amid growth”That’s funny :D
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.